Thurman JM - Search Results

1

Sublytic membrane-attack-complex activation and VEGF secretion in retinal pigment epithelial cells.

Kunchithapautham K, Bandyopadhyay M, Dahrouj M, Thurman JM, Rohrer B. Kunchithapautham K, et al. Among authors: thurman jm. Adv Exp Med Biol. 2012;723:23-30. doi: 10.1007/978-1-4614-0631-0_4. Adv Exp Med Biol. 2012. PMID: 22183311 No abstract available.

2

Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury.

Thurman JM, Renner B, Kunchithapautham K, Ferreira VP, Pangburn MK, Ablonczy Z, Tomlinson S, Holers VM, Rohrer B. Thurman JM, et al. J Biol Chem. 2009 Jun 19;284(25):16939-16947. doi: 10.1074/jbc.M808166200. Epub 2009 Apr 21. J Biol Chem. 2009. PMID: 19386604 Free PMC article.

3

A targeted inhibitor of the complement alternative pathway reduces RPE injury and angiogenesis in models of age-related macular degeneration.

Rohrer B, Long Q, Coughlin B, Renner B, Huang Y, Kunchithapautham K, Ferreira VP, Pangburn MK, Gilkeson GS, Thurman JM, Tomlinson S, Holers VM. Rohrer B, et al. Among authors: thurman jm. Adv Exp Med Biol. 2010;703:137-49. doi: 10.1007/978-1-4419-5635-4_10. Adv Exp Med Biol. 2010. PMID: 20711712

4

Aseptic injury to epithelial cells alters cell surface complement regulation in a tissue specific fashion.

Thurman JM, Renner B, Kunchithapautham K, Holers VM, Rohrer B. Thurman JM, et al. Adv Exp Med Biol. 2010;664:151-8. doi: 10.1007/978-1-4419-1399-9_18. Adv Exp Med Biol. 2010. PMID: 20238013

5

Noninvasive detection of complement activation through radiologic imaging.

Thurman JM, Rohrer B. Thurman JM, et al. Adv Exp Med Biol. 2013;735:271-82. doi: 10.1007/978-1-4614-4118-2_19. Adv Exp Med Biol. 2013. PMID: 23402034 Review.

6

New therapeutic and diagnostic opportunities for injured tissue-specific targeting of complement inhibitors and imaging modalities.

Holers VM, Tomlinson S, Kulik L, Atkinson C, Rohrer B, Banda N, Thurman JM. Holers VM, et al. Among authors: thurman jm. Semin Immunol. 2016 Jun;28(3):260-7. doi: 10.1016/j.smim.2016.05.007. Epub 2016 Jun 6. Semin Immunol. 2016. PMID: 27282113 Free PMC article. Review.

7

Detection of complement activation using monoclonal antibodies against C3d.

Thurman JM, Kulik L, Orth H, Wong M, Renner B, Sargsyan SA, Mitchell LM, Hourcade DE, Hannan JP, Kovacs JM, Coughlin B, Woodell AS, Pickering MC, Rohrer B, Holers VM. Thurman JM, et al. J Clin Invest. 2013 May;123(5):2218-30. doi: 10.1172/JCI65861. Epub 2013 Apr 24. J Clin Invest. 2013. PMID: 23619360 Free PMC article.

8

Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction.

Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE. Girardi G, et al. Among authors: thurman jm. J Exp Med. 2006 Sep 4;203(9):2165-75. doi: 10.1084/jem.20061022. Epub 2006 Aug 21. J Exp Med. 2006. PMID: 16923853 Free PMC article.

9

Tissue-targeted complement therapeutics.

Tomlinson S, Thurman JM. Tomlinson S, et al. Among authors: thurman jm. Mol Immunol. 2018 Oct;102:120-128. doi: 10.1016/j.molimm.2018.06.005. Epub 2018 Jul 7. Mol Immunol. 2018. PMID: 30220307 Free PMC article. Review.

10

Endothelial Microparticles and Systemic Complement Activation in Patients With Chronic Kidney Disease.

Jalal D, Renner B, Laskowski J, Stites E, Cooper J, Valente K, You Z, Perrenoud L, Le Quintrec M, Muhamed I, Christians U, Klawitter J, Lindorfer MA, Taylor RP, Holers VM, Thurman JM. Jalal D, et al. Among authors: thurman jm. J Am Heart Assoc. 2018 Jul 13;7(14):e007818. doi: 10.1161/JAHA.117.007818. J Am Heart Assoc. 2018. PMID: 30006493 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

169 results

Search Page